Adeza
Test assesses risk of preterm birth
Published in FDA Law Weekly, May 26th, 2005
The test is U.S. Food & Drug Administration (FDA)-approved for the broad use of assessing the risk of preterm birth. It determines the presence of the fetal fibronectin protein in the birth canal. This adhesive protein works like a "glue," holding the maternal and fetal membranes together during pregnancy.
Fetal fibronectin is typically not present until the final 2 to 6 weeks of pregnancy. Women who are considered at high risk for preterm birth or who experience early signs and symptoms of labor - between 22 and 35...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
Source: FDA Law Weekly (2005-05-26)
More Articles from FDA Law Weekly
- AMTSystems
Identification device for surgical safety introduced in healthcare industry - Adventrx Pharmaceuticals, Inc.
U.S. FDA grants clearance for CoFactor phase III trial in colorectal cancer - Alcon, Inc.
New intraocular lens launched - BioAlliance Pharma
U.S. FDA grants orphan drug designation for doxorubicin Transdrug - Cellegy Pharmaceuticals, Inc.
Pharmaceutical firm responds to U.S. FDA inquiries about Cellegesic - Centers for Medicare & Medicaid Services
CMS proposes FY 2006 rate increases for inpatient stays in acute care hospitals - More from this issue of FDA Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
